Global Birth Control Pills 麻豆原创 Research Report 2024

Publication ID:

PB501242089

Publication Date:

January 24, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Oral contraceptives (birth control pills) are medications that prevent pregnancy. They are one method of birth control. Oral contraceptives are hormonal preparations that may contain combinations of the hormones estrogen and progestin or progestin alone. Combinations of estrogen and progestin prevent pregnancy by inhibiting the release of the hormones luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary gland in the brain.
The global Birth Control Pills market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Birth Control Pills is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Birth Control Pills is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Birth Control Pills in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Birth Control Pills include Merck, Pfizer, Teva Pharmaceutical, Bayer, Allergan, Janssen, Mankind Pharma, Piramal Enterprises and Reckitt Benckiser, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Birth Control Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Birth Control Pills.
Report Scope
The Birth Control Pills market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Birth Control Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Birth Control Pills companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Merck
Pfizer
Teva Pharmaceutical
Bayer
Allergan
Janssen
Mankind Pharma
Piramal Enterprises
Reckitt Benckiser
Church & Dwight
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Segment by Application
Hospital Pharmacy
Independent Pharmacy
Online Pharmacy
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Birth Control Pills companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Birth Control Pills 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Contraceptives
1.2.3 Contraceptive Injectable
1.3 麻豆原创 by Application
1.3.1 Global Birth Control Pills 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Independent Pharmacy
1.3.4 Online Pharmacy
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Birth Control Pills 麻豆原创 Perspective (2019-2030)
2.2 Birth Control Pills Growth Trends by Region
2.2.1 Global Birth Control Pills 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Birth Control Pills Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Birth Control Pills Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Birth Control Pills 麻豆原创 Dynamics
2.3.1 Birth Control Pills Industry Trends
2.3.2 Birth Control Pills 麻豆原创 Drivers
2.3.3 Birth Control Pills 麻豆原创 Challenges
2.3.4 Birth Control Pills 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Birth Control Pills Players by Revenue
3.1.1 Global Top Birth Control Pills Players by Revenue (2019-2024)
3.1.2 Global Birth Control Pills Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Birth Control Pills 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Birth Control Pills Revenue
3.4 Global Birth Control Pills 麻豆原创 Concentration Ratio
3.4.1 Global Birth Control Pills 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Birth Control Pills Revenue in 2023
3.5 Birth Control Pills Key Players Head office and Area Served
3.6 Key Players Birth Control Pills Product Solution and Service
3.7 Date of Enter into Birth Control Pills 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Birth Control Pills Breakdown Data by Type
4.1 Global Birth Control Pills Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Birth Control Pills Forecasted 麻豆原创 Size by Type (2025-2030)
5 Birth Control Pills Breakdown Data by Application
5.1 Global Birth Control Pills Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Birth Control Pills Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Birth Control Pills 麻豆原创 Size (2019-2030)
6.2 North America Birth Control Pills 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Birth Control Pills 麻豆原创 Size by Country (2019-2024)
6.4 North America Birth Control Pills 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Birth Control Pills 麻豆原创 Size (2019-2030)
7.2 Europe Birth Control Pills 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Birth Control Pills 麻豆原创 Size by Country (2019-2024)
7.4 Europe Birth Control Pills 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Birth Control Pills 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Birth Control Pills 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Birth Control Pills 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Birth Control Pills 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Birth Control Pills 麻豆原创 Size (2019-2030)
9.2 Latin America Birth Control Pills 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Birth Control Pills 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Birth Control Pills 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Birth Control Pills 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Birth Control Pills 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Birth Control Pills 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Birth Control Pills 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Birth Control Pills Introduction
11.1.4 Merck Revenue in Birth Control Pills Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Birth Control Pills Introduction
11.2.4 Pfizer Revenue in Birth Control Pills Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Detail
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Birth Control Pills Introduction
11.3.4 Teva Pharmaceutical Revenue in Birth Control Pills Business (2019-2024)
11.3.5 Teva Pharmaceutical Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Birth Control Pills Introduction
11.4.4 Bayer Revenue in Birth Control Pills Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Birth Control Pills Introduction
11.5.4 Allergan Revenue in Birth Control Pills Business (2019-2024)
11.5.5 Allergan Recent Development
11.6 Janssen
11.6.1 Janssen Company Detail
11.6.2 Janssen Business Overview
11.6.3 Janssen Birth Control Pills Introduction
11.6.4 Janssen Revenue in Birth Control Pills Business (2019-2024)
11.6.5 Janssen Recent Development
11.7 Mankind Pharma
11.7.1 Mankind Pharma Company Detail
11.7.2 Mankind Pharma Business Overview
11.7.3 Mankind Pharma Birth Control Pills Introduction
11.7.4 Mankind Pharma Revenue in Birth Control Pills Business (2019-2024)
11.7.5 Mankind Pharma Recent Development
11.8 Piramal Enterprises
11.8.1 Piramal Enterprises Company Detail
11.8.2 Piramal Enterprises Business Overview
11.8.3 Piramal Enterprises Birth Control Pills Introduction
11.8.4 Piramal Enterprises Revenue in Birth Control Pills Business (2019-2024)
11.8.5 Piramal Enterprises Recent Development
11.9 Reckitt Benckiser
11.9.1 Reckitt Benckiser Company Detail
11.9.2 Reckitt Benckiser Business Overview
11.9.3 Reckitt Benckiser Birth Control Pills Introduction
11.9.4 Reckitt Benckiser Revenue in Birth Control Pills Business (2019-2024)
11.9.5 Reckitt Benckiser Recent Development
11.10 Church & Dwight
11.10.1 Church & Dwight Company Detail
11.10.2 Church & Dwight Business Overview
11.10.3 Church & Dwight Birth Control Pills Introduction
11.10.4 Church & Dwight Revenue in Birth Control Pills Business (2019-2024)
11.10.5 Church & Dwight Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck
Pfizer
Teva Pharmaceutical
Bayer
Allergan
Janssen
Mankind Pharma
Piramal Enterprises
Reckitt Benckiser
Church & Dwight

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.